Global Immunoglobulins Market is Estimated to Value Over USD 16 Billion by 2026 End

  • 01 Nov 2019
  • Healthcare

Global Immunoglobulins Market is estimated to value over USD 16 billion by 2026 end and register a CAGR of over 6.4% during the forecast period 2019 to 2026.

The sizeable global immunoglobulins market growth during the forecast timeline can be attributed to many reasons, namely, the growing volume of people afflicted with hemophilia, the boost in the geriatric population, advancements in the immunoglobulin production and the introduction of innovative technologies. All these factors are strong markers of the augmentation of the global immunoglobulins market size. In addition, the presence of hypogammaglobinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), and others are factors that are projected to stimulate the market growth. 

Positive changes in the infrastructural framework of the healthcare sector, a boost in the funding of research and development, alternative therapies in immunoglobulins as well as major expenditure in healthcare are expected to propel the global immunoglobulins market growth. Shifts in technology have been instrumental in driving the market proliferation. There is also a greater adoption of novelty treatment and drug catering to the area of intravenous immunoglobulin.

Abeona Therapeutics, Inc. deals in the production of products that are plasma-based as well as in the production of gene therapy. These endeavors are carried out for the treatment of diseases which are potentially life threatening. There have conducted evolutions and expansions of salt diafiltration procedure which entails the extraction and purification of plasma proteins from the plasma of human bodies. The company has conducted ranges that entails salt precipitation process which is a two-step procedure and allows for resultant SDF fractions. These fractions have high levels of immunoglobulins and alpha-1 protease inhibitor, when it is placed in comparison to Cohn process.

Abeona evaluates the process in identifying proteins that are ultra-orphan, so that the SDF process can now acquire optimization and has put forth a program that finalizes the downstream purification process for SDF IVIG. Preliminary assessment for SDF beginning with the fractions stipulates that the process should be advantageous for the alienation of a number of ultra-orphan proteins that includes Factor H and von Willebrand's factor, fibrinogen and plasminogen. Furthermore, the company has declared that it shall be conducting a session with the FDA to engage in conversations about more developments and allow for a better pathway for the protein products containing SDF.

The major players in the market for immunoglobulins include BDI Pharma (US), Grifols Inc. (Spain), Abeona Therapeutics (US), Biotest AG. (Germany), Baxter (US), Octapharma (Switzerland), China Biologic Products, Inc. (China), Kedrion S.p.A (US), Shire (Republic of Ireland) and CSL Behring (US)


Global Immunoglobulins Market Segmentation:

By Application

  • Hypogammaglobinemia
  • Chronic Inflammatory Demyelinating polyneuropathy (CIDP)
  • Primary Immunodeficiency Diseases
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Inflammatory Myopathies
  • Specific Antibody Deficiency
  • Guillain-Barre Syndrome
  • Guillain-Barre Syndrome
  • Others

By Product

  • IGG
  • IGA
  • IGE
  • IGD

By Mode of Delivery

  • Intravenous
    • 5% Concentration
    • 10% Concentration
    • Other Concentrations
  • Subcutaneous
    • 6.5% Concentration
    • 20% Concentration
    • Other Concentrations

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East & Africa

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the global immunoglobulins market by product, by application, by mode of delivery and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
  • To record evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Get unlimited analyst support and customise this study further to your requirements, contact